1.
Tran TB, Doan TKC. SOME RISK FACTORS OF CARDIOVASCULAR-METABOLISM AND EVALUATION OF TREATMENT RESULTS WITH EMPAGLIFLOZIN COMBINED METFORMIN IN TYPE 2 DIABETES WITH OVERWEIGHT AND OBESITY. CTJUMP. 2026;(33):10-16. Accessed August 27, 2026. https://tapchi.ctump.edu.vn/index.php/ctump/article/view/1181